Background: Poststroke rehabilitation reportedly improves functional outcomes and minimizes disability. However, previous studies have demonstrated conflicting results regarding the effects of rehabilitation therapy on post-stroke mortality. Therefore, we aimed to investigate the association between rehabilitation therapy within the first six months after stroke and long-term all-cause mortality in patients with stroke using data from the Korean National Health Insurance System. Methods: A total of 10,974 patients newly diagnosed with stroke using ICD-10 codes (I60-I64) between 2013 and 2019 were enrolled and followed-up for all-cause mortality until 2019. Post-stroke patients were categorized into three groups according to the frequency of rehabilitation therapy: no rehabilitation therapy, ?≤ 40 sessions, and > 40 sessions. Cox proportional hazard models were used to assess the mortality risk according to rehabilitation therapy stratified by disability severity. Results: Higher frequency of rehabilitation therapy was associated with significantly lower post-stroke mortality in comparison to no rehabilitation therapy (HR=0.88, 95% CI 0.79-0.99), especially among individuals with severe disability after stroke (HR=0.74, 95% CI 0.62-0.87). An inverse association between number of rehabilitation therapy sessions and mortality was identified in a multivariate Cox regression model with restricted cubic splines. In the context of stroke type, higher frequency of rehabilitation therapy was associated with reduced mortality rates compared to no rehabilitation therapy only in patients with hemorrhagic stroke (HR=0.60, 95% CI 0.49-0.74). While socioeconomic factors were not associated with mortality, older age, male sex, and pneumonia were associated with increased mortality risk, regardless of disability severity. Conclusions: Post-stroke rehabilitation therapy within six months of stroke onset seems to play a substantial role in reducing long-term mortality after stroke. A higher frequency of rehabilitation therapy is recommended for post-stroke patients, particularly among those with severe disability.

The authors have declared no competing interest.

The authors received no financial support for the research.

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This study was approved by the Institutional Review Board of the Korea University Guro Hospital, which waived the need for informed consent.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

The data are available from the corresponding author on reasonable request.